Dr. Jeffrey L. Cummings In The News
Philanthropy News Digest
The University of Nevada, Las Vegas has announced a $6 million commitment from Joy Chambers-Grundy and the late Reg Grundy to establish a center dedicated to research on and the treatment of neurological disorders.
![Las Vegas Review Journal](/sites/default/files/styles/100_width_25_height/public/news_source/logo/las-vegas-review-journal.jpg?itok=IX9YBkgU)
![Newswise](/sites/default/files/styles/100_width_25_height/public/news_source/logo/newswise.png?itok=_CT4oU3W)
![Yahoo!](/sites/default/files/styles/100_width_25_height/public/news_source/logo/yahoo-logo.png?itok=_QObPPuO)
![Bloomberg](/sites/default/files/styles/100_width_25_height/public/news_source/logo/bloomberg-logo.png?itok=52fXM8Yt)
![P.B.S.](/sites/default/files/styles/100_width_25_height/public/news_source/logo/pbs.png?itok=MbrxhKBU)
MarketWatch
China has approved its first homegrown Alzheimer’s treatment — a novel drug based on algae, and the first breakthrough since 2003 in a field that has frustrated scientists and drug companies for decades.
PR Newswire
Shanghai Green Valley Pharmaceuticals (Green Valley) announced today that China's National Medical Products Administration ( ANPM ) has approved oligo manato (GV-971) as a new drug for treatment of "Alzheimer's disease (AD) from benign to moderate and to improve cognitive function".